Skip to main content
Watch Insiders

Corporate insider profile

Helen Torley Insider Trades

Latest reported as PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC. (HALO).

Purchase filings
0
Reported companies
1
Net open-market value
-$26,280,077.59
Latest transaction
Oct 8, 2026

Affiliated corporations

Reported company relationships

HALOLatest reported

HALOZYME THERAPEUTICS, INC.

PRESIDENT AND CEO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 8, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale60,000$110.18$6,610,500
Sep 11, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale60,000$107.28$6,436,710
Aug 19, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale60,000$104.59$6,275,592
Jul 8, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale1,923$79.77$153,391
Jun 3, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale50,000$67.40$3,370,010
May 13, 2026HALOZYME THERAPEUTICS, INC. (HALO)PRESIDENT AND CEOSale50,000$68.68$3,433,875